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Background: Schizophrenia is a complex psychiatric disorder characterized by high phenotypic heterogeneity.
Previous studies have distinguished between familial and sporadic forms of schizophrenia and have suggested
clinical differentiation between patients and relatives from sporadic and multiplex families. We will introduce a
more refined method to distinguish between family subtypes based on psychosis dimension profiles in the relatives
of schizophrenia patients.
Methods: Positive, negative, disorganization, mania, and depression scores were assessed in 1,392 relatives. Mixed
Model Latent Class Analysis was used to identify family subtypes. A family subtype is a relatively homogeneous
group of families with similar symptom profiles in the relatives in these families. Next, we investigated in 616
schizophrenia patients whether family subtype was associated with symptom profiles, IQ, cannabis dependence/
abuse, or age of onset of psychosis.
Results: Based on the data of relatives, we identified two different family types: “healthy” and “at risk for psychiatric
disorder”. Patients from at risk families obtained higher positive scores compared to patients from healthy families
(Wald(1) = 6.6293, p = 0.010). No significant differences were found in any of the remaining variables.
Conclusions: Our findings confirm the existence of high-risk families and although we did not establish an
etiological basis for the distinction between family types, genetic studies might reveal whether family subtype is
associated with genetic heterogeneity.
Keywords: Family subtype, Familial loading, Multiplex, Sporadic, Phenotypic heterogeneity, Schizophrenia, Controls,
Factor analysis, Latent class analysis, Mixed model latent class analysisBackground
Schizophrenia is a complex psychiatric disorder charac-
terized by high phenotypic heterogeneity within patients
[1-3]. This phenotypic heterogeneity has been studied
using factor analysis (i.e., variation in symptoms being
explained by continuous latent factors) and latent class
analysis (i.e., variation in symptoms being explained by
the presence of different clusters of patients) or a* Correspondence: e.m.derks@amc.uva.nl
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reproduction in any medium, provided the orcombination of these approaches [3,4]. We previously
reported on the existence of five latent dimensions (i.e.,
disorganization, positive, negative, mania, and depres-
sion) and seven different classes of subjects in a large
sample (N> 4,000) of schizophrenia patients, their rela-
tives and healthy controls. The classes and dimensions
were validated by showing associations with IQ and
daily functioning [3], and progressive volume changes
in brain volumes in schizophrenia patients [5]. In the
present study, we will extend these previous analyses by
incorporating heterogeneity at the family level using a rela-
tively new statistical approach: mixed model Latent Class
Analysis. We aim to distinguish between different family
subtypes based on psychosis dimension scores assessed intd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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measure compared to diagnosis, our study may facilitate
the investigation of the etiological causes of schizophrenia
by improving the distinction between familial and sporadic
forms of schizophrenia.
Previous studies have distinguished between familial and
sporadic forms of schizophrenia by investigating differences
between multiplex (i.e., pedigrees with multiple affected
individuals) and sporadic (i.e., families with a single affected
individual) families. Even though schizophrenia is a highly
heritable disorder [6,7], the majority of the schizophrenia
patients are sporadic cases, which is expected under the
genetic liability model as shown by Yang and colleagues [8].
It is yet unclear whether multiplex and sporadic families
are characterized by different etiological factors. Studies
comparing sporadic versus multiplex families have revealed
a relatively low age of onset [9], poor outcome [9,10] and
more impairment of working memory [11] in patients from
multiplex families. However, sporadic cases showed more
alcohol abuse [12]. Likewise, non-psychotic siblings of
patients in multiplex families showed decreased cognitive
functioning including impaired sustained attention [13],
worse performance on visual working memory tasks [14]
and more executive deficits [15]. Whether these clinical dif-
ferences are representative of heterogeneity in the under-
lying etiology needs further investigation.
Unfortunately, previous studies are hindered by an over-
simplified distinction between sporadic and multiplex
families as some of the relatives of patients with schizo-
phrenia may not meet the criteria for a psychiatric diagno-
sis but may suffer from subclinical psychosis symptoms
[16]. Family members of schizophrenia patients may be
more prone to show a broad range of subclinical symptoms
compared to the general population; these symptoms may
therefore be important to identify family subtypes. We will
use multilevel Latent Class analysis (LC) developed by
Asparouhov and Muthen [17], and Vermunt [18] as this
approach allows for the identification of classes of families
with similar patterns of symptom dimension scores in sub-
jects belonging to these families.
In this paper we will address two questions. First, we will
investigate whether different subtypes of families can be
distinguished based on psychosis dimension scores in rela-
tives of schizophrenia patients. Second, we will investigate
whether there is an association between family subtype and
risk factors for schizophrenia (e.g., cannabis use), or patient
characteristics (e.g., IQ, psychosis dimension scores).
Methods
Subjects
Subjects were recruited as part of the Genetic Risk and
Outcome of Psychosis (GROUP). In the GROUP study,
patients were identified in selected representative geograph-
ical areas in the Netherlands and Belgium. All patients metthe following criteria: (1) age between 16 and 50, (2) Diag-
nostic and Statistical Manual of Mental Disorders, Fourth
Edition (DSM-IV) criteria for a psychotic disorder (includ-
ing schizophrenia, schizophreniform disorder, and schizoaf-
fective disorder), (3) fluency in Dutch, and (4) written
informed consent. Eligible siblings of schizophrenia patients
(brothers and/or sisters) fulfil the criteria of (1) age between
18 and 50 (extremes included), (2) fluency in Dutch, and
(3) written informed consent; except for the age criterion,
similar criteria applied to the parents. The GROUP study
was approved by the Medical Ethics Committee (METC) of
UMC Utrecht, the Netherlands and all subjects gave writ-
ten informed consent in accordance with the committee’s
guidelines.
In this study we included data of families with at least
one participating relative. In one of the four participating
centers, DSM-IV diagnosis was assessed with the Schedules
for Clinical Assessment in Neuropsychiatry (SCAN) instead
of the Comprehensive Assessment of Symptoms and His-
tory (CASH) and patients recruited in this center were
excluded from analyses due to incompatibility of the symp-
tom assessment. The resulting sample included 1,392 rela-




All subjects were assessed with the Comprehensive As-
sessment of Symptoms and History (CASH) interview
[19]. Interviews were administered by research assistants
(primarily psychologists and psychiatrists) who attended
structured training workshops. Assessments were super-
vised by WC, LdH, RB, IM-G, or LK for the GROUP
study, and by WC or RH for the Utrecht study. A subset
of 63 items was used to estimate factor scores of five
underlying dimensions: positive, negative, depression,
mania, and disorganisation [3]. Due to the non-
normality of the distribution of the factor scores, we
recoded the continuous scores and created an ordinal
three-point scale.
Cannabis
Based on the lifetime rated Cannabis abuse subscale of
the Composite International Diagnostic Interview (CIDI;
[20]), a distinction was made between four groups of
subjects: no dependence or abuse, dependence, abuse,
and dependence and abuse. Cannabis dependence/abuse
was rated in all 616 patients.
WAIS-IQ
All subjects were assessed with a comprehensive neuro-
cognitive test battery containing the following tasks
(intended cognitive domains of focus are placed between
brackets): WAIS-III Digit Symbol–Coding (processing
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vigilance) (16, 17), Word Learning Task (verbal learning
and memory) (18), WAIS-III Arithmetic (working mem-
ory) (15), WAIS-III Block Design (reasoning and problem
solving) (15), Response Shifting Task (set-shifting), which
is a modified version of the Competing Programs Task
(19, 20), and WAIS-III Information (verbal comprehen-
sion) (15). To calculate a measure of global cognitive func-
tioning (i.e., IQ), raw test scores were converted into
standardized z-scores against the means and standard
deviations of the healthy control group. Z-scores were cal-
culated for each cognitive domain and were recoded if ne-
cessary such that more negative z-scores reflected worse
performance for all measures. IQ was assessed in 604
(98%) of the patients.
Camberwell assessment of need
The Camberwell Assessment of Need (CAN) rating scale
[21] was used to assess met and unmet clinical and so-
cial needs in the patients participating in the GROUP
study. The CAN rating scale consists of 22 items rated
on a 0–2 scale. The CAN was assessed in 582 (95%) of
the patients.
Age of onset first psychosis
The age of onset of the first psychotic symptoms was
assessed based on the CASH interview and was com-
pleted by 614 (99.7%) of the patients.
Statistical analyses
For a formal introduction to the multilevel LC model,
we refer to Vermunt [18]. We used the non-parametric
variant of the multilevel LC model. In short, in this
model differences across groups (i.e., families) are mod-
eled using a discrete latent variable at the group level.
There are three levels present in this analysis. First, there
are the observed responses (e.g., symptom ratings) of an
individual at the lowest level. Next, individuals may be
clustered using a lower level LC, this step corresponds
to a conventional LC analysis (e.g., identification of
symptom profiles). The lower level latent classes are
assumed to differ in the distribution of the observed
responses. At the third and highest level, the family
structure of the data is taken into account. The higher
level LCs differ in the distribution of the lower-level LCs
and group families into different family types. When
selecting the best-fitting model, a decision has to be
made both on the number of lower-level and of higher-
level LCs. We followed the guidelines proposed by
Lukociene et al. [22] and performed a three-step proced-
ure. First, we determined the number of lower-level
classes ignoring the multilevel (family) structure of the
data. Second, we fixed the number of lower-level classes
to the value of step 1 and determined the number ofhigher-level classes. Third, we fixed the number of
higher-level classes to the value of step 2 and redeter-
mined the number of lower-level classes. Model fit of
nested models was compared based on the Bayesian In-
formation Criterion (BIC) [23] which is the preferred
criterion for simultaneously deciding about the number
of lower- and higher-level classes [22]. The BIC was cal-
culated using the number of families as the number of
observations. Statistical analyses were performed in
LatentGold [24] scripts will be made available at
request).
After establishing the presence of distinctive family
subtypes, we compared variables of interest between
family subtypes. To adjust for possible classification
errors occurring when assigning families to their most
likely (modal) class, in these post-hoc analyses, we used
the modified BCH adjustment as described by Vermunt
[25]. This approach involves constructing an expanded
data set with the inverse of the classification error
matrix as weights. Parameter estimation in subsequent
analyses involves maximizing a weighted log-likelihood
for clustered data, which means that complex sampling
variance estimation methods need to be used to obtain
correct statistical tests. First, we tested which specific
symptoms were scored significantly different by the rela-
tives of the different family subtypes. Next, we investi-
gated the validity of family subtypes by testing whether
CASH symptom dimension scores in patients were sig-
nificantly different between family subtypes. The type-I
error rate was Bonferroni corrected for the five tests that
were performed and was set at .05/5 = .01. We also
investigated whether the etiological measures: WAIS-IQ,
CAN met and unmet needs, Cannabis abuse/depend-
ence, and age of onset first psychosis differed signifi-
cantly between family subtypes. Again, the type-I error
rate was set at .01.
Results
Mixed model latent class analyses
As mentioned in the method Statistical Analyses section,
we used a three-step procedure to decide on the number
of lower-level and higher-level latent classes (see Table 1).
At step 1, we included only one higher-level class and
increased the number of lower-level latent classes.
According to the BIC, a model with nine lower-level la-
tent classes provided the best fit. Next, we tested
whether the model fit improved if the number of higher-
level classes was increased. Our analyses showed that a
model with 2 higher-level latent classes provided a better
fit compared to a model with one or three higher-level
latent classes. Finally, we tested whether the optimal
number of lower-level latent classes changed due to the
inclusion of two higher-level latent classes. The number
of lower-level latent classes did not change: our final
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higher level classes. In other words, individual subjects
were assigned to nine different classes while we identi-
fied two different types of families. The 2 group-9 class
model is visualized in Figures 1 and 2. Figure 1 shows
the mean dimension scores in the nine individual-level
latent classes. Figure 2 represents the latent class prob-
abilities in the two family subtypes. Slightly more fam-
ilies were identified as “at risk for psychiatric disorder”
families (57%) than “healthy” (43%). While subjects
assigned to the “healthy” family type have a high chance
(73%) of being assigned to the no-symptoms class
(Cluster 9), subjects from "at risk for psychiatric dis-
order" families have a 20% chance of being assigned to
the no-symptoms class while the remaining 80% is
assigned to any of the other classes (see Figure 2).
Table 2 shows the demographic data in the relatives in
the total sample and by family type.
We have performed a simulation study to investigate
the statistical power to differentiate between the 1
group-9 class model and the 2 group-9 class model. Data
were simulated with the estimates of the best fitting
model as parameter values; 500 replicates were per-
formed. The fit of the two models was compared based
on the BIC. The results of this simulation study showed
that the 2 group-9 class model provided a better fit com-
pared to the 1 group-9 class model in 492 of the 500Table 1 Comparison of model fit in the Mixed Model LCA ana
STEP 1, determine the number of lower-level latent classes
Model 1. 1 higher-level latent class, 1 lower-level latent class
Model 2. 1 higher-level latent class, 2 lower-level latent classes
Model 3. 1 higher-level latent class, 3 lower-level latent classes
Model 4. 1 higher-level latent class, 4 lower-level latent classes
Model 5. 1 higher-level latent class, 5 lower-level latent classes
Model 6. 1 higher-level latent class, 6 lower-level latent classes
Model 7. 1 higher-level latent class, 7 lower-level latent classes
Model 8. 1 higher-level latent class, 8 lower-level latent classes
Model 9. 1 higher-level latent class, 9 lower-level latent classes
Model 10. 1 higher-level latent class, 10 lower-level latent classes
STEP 2, determine the number of higher-level latent classes
Model 11. 1 higher-level latent class, 9 lower-level latent classes (=model 9)
Model 12. 2 higher-level latent classes, 9 lower-level latent classes
Model 13. 3 higher-level latent classes, 9 lower-level latent classes
STEP 3, redetermine the number of lower-level latent classes
Model 14. 2 higher-level latent classes, 8 lower-level latent classes
Model 15. 2 higher-level latent classes, 9 lower-level latent classes (=m
Model 16. 2 higher-level latent classes, 10 lower-level latent classes
Note: the best-fitting models in each of the steps are shown in bold.replicates (98%) which shows that the statistical power
to differentiate between these models is excellent.
A more detailed Investigation of the family subtypes
The two family subtypes are distinguished based on the la-
tent class probabilities of individuals belonging to a particu-
lar family. The individual latent classes are characterized by
a particular profile on the five psychosis dimensions. The
data reported in Table 2 show that all five symptom dimen-
sion scores were significantly higher in “at risk for psychi-
atric disorder” compared to “healthy” families (all p < .001).
As the prevalence of depression is also higher in relatives
from “at risk for psychiatric disorder” families (28.6% com-
pared to 6.6% in healthy families), we investigated whether
the higher depression rate explained the different psychosis
dimension scores, by repeating the analysis in relatives un-
affected for depression. The differences between relatives
from the two subtypes became somewhat smaller, but were
still highly significant.
We next explored whether particular symptoms are re-
sponsible for the distinction between family subtypes.
To this end, we compared the 63 symptoms directly be-
tween the “at risk for psychiatric disorder” and “healthy”
families. The mean scores of the two family types are
shown in Figure 3. We performed one-sided statistical
tests to investigate which symptoms are more prevalent in
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Figure 1 Mean dimension scores by latent class.
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The majority of the positive (15/16 symptoms, 94%), de-
pression symptoms (18/18 symptoms, 100%), and mania
symptoms (6/7 symptoms, 86%) were more prevalent in
“at risk for psychiatric disorder” families compared to
“healthy” families”. In contrast, few of the negative (1/10
symptoms, 10%) or disorganization (5/12 symptoms, 42%)
were significantly different between family subtypes.
We also explored whether differences in symptom di-
mension scores between family subtypes were present only
in siblings or parents. The results show that differences
are similar in these two types of relatives (see Table 3).
A comparison of patients from “at risk for psychiatric
disorder” and “healthy” families
Clinical characteristics
Lifetime assessed psychosis dimension scores indicated
higher positive symptom scores in patients from “at risk
for psychiatric disorder” families compared to patients
from “healthy” families (Wald(1) = 6.6293, p = 0.010).
There were no apparent differences in the other symp-
tom domains, including negative, disorganization, mania,
general, and depression symptoms (all p > 0.10). There
were also no significant differences in the remaining
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Figure 2 Latent class probability by family type.number of met or unmet needs. The results of these
analyses are summarized in Table 4.
Etiological factors
The hypothesized etiological factors (i.e., cannabis (ab)
use or dependence and age of onset) were not signifi-
cantly different between patients from the two different
family types (see Table 4).
Discussion
Using psychosis dimension scores assessed in a sample
1,392 relatives of schizophrenia patients from 671 fam-
ilies we identified two family subtypes: “at risk for psy-
chiatric disorder” and “healthy”. These family subtypes
were mainly distinguished based on depression, mania,
and positive symptoms. We subsequently investigated
whether patient characteristics were different between
family types. A difference was revealed in the level of
positive symptoms; patients from “at risk for psychiatric
disorder” families obtained higher positive symptom
scores compared to patients from “healthy” families.
Previous studies have distinguished between sporadic
and multiplex families based on either a simple distinction
between families with one or more schizophrenia patients,
or using a more sophisticated algorithm which takes the
number of family members, the degree of genetic related-
ness, age at the time of the study and gender into account
[26]. Differences in clinical presentation of patients from
sporadic and multiplex families have been reported, but
results were inconsistent; it remained unclear whether
clinical differences represented etiological heterogeneity.
In the present study, we used a relatively new statistical
approach to perform a family based analysis of the sub-
clinical levels of psychosis in family members of schizo-
phrenia patients. We identified two different family types:
42% of the families was assigned to the “healthy” family
class while 58% of the families was assigned to the “at risk
for psychiatric disorder” family class. Relatives assigned to
the “at risk for psychiatric disorder” were more often diag-
nosed with depression and obtained higher scores on the
Table 2 Overview of demographic and clinical data in relatives in the total sample and by family subtype
Total sample (N= 1392) “Healthy” (N = 637) “At risk” (N = 755) Test statistic (df) P
Mean age (SD) 40.37 (15.68) 40.40 (15.41) 40.35 (15.91) Wald(1) = .00 .95
N male (%) 605 (43.5) 280 (44.0) 325 (43.0) Wald(1) = .12 .73
N diagnosis (%) Control 1111 (79.8) 586 (92) 525 (69.5) Wald(2) = 95.93 <.001
Depression 258 (18.5) 42 (6.6) 216 (28.6)
Rest 23 (1.7) 9 (1.4) 14 (1.8)
WAIS-IQ 103.65 (16.15) 104.11 (15.72) 103.28 (15.91) Wald(1) = 0.90 .34
Note:
- As a posthoc analysis, we repeated these analyses in relatives unaffected for depression. The differences between relatives from the two subtypes became
somewhat smaller, but were still highly significant.
- These analyses were performed in LatentGold and were corrected for family structure by taking into account possible correlations within families.
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sion, mania, and disorganization) compared to relatives
from “healthy families”. The higher psychosis dimension
scores were not solely due to the higher prevalence of de-
pression, as the differences between relatives were slightly
less pronounced but still significantly different in relatives
unaffected for depression (data not shown).
The main novelty of the approach presented in this
article is the use of refined phenotypes to define family
subtype. The distinction between family types is based
on symptom dimension scores of all participating family
members instead of a dichotomous distinction between
affected and unaffected. Although our approach is much
more labor-intensive in terms of data collection (i.e., the
collection of symptoms instead of psychosis yes/no) the
extra information appears to contribute to a valid assess-
ment of family type.
Patients from the “at risk for psychiatric disorder” fam-
ily type obtained higher scores on lifetime rated positive
symptoms (i.e., the CASH positive dimension) compared
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Figure 3 Mean scores on specific symptoms in the relatives of “healthwas specific for positive symptoms; no differences were
found for the remaining symptom dimensions, IQ, the
number of needs, Cannabis abuse/dependence or age of
onset of psychosis. This is in contrast to the scores in
relatives while parents and siblings of the different fam-
ily subtypes obtain different symptom scores on all five
psychosis dimensions, with the largest differences found
for positive, depression, and mania dimensions.
We will discuss two competing explanations for our find-
ings which indicate that positive symptoms in patients are
most strongly associated with positive, depression, and
mania scores in their relatives and not with negative and
disorganization symptoms. The first argument will be built
on the premise that schizophrenia results from an increased
risk for cognitive deterioration and an increased risk for
psychotic features. We have previously shown the existence
of a subset of schizophrenia patients with relatively low
disorganization and negative symptoms and normal cogni-
tive functioning [3]. This suggests that disorganization and
negative symptoms may be indicators, or clinical correlates,






























































































































































































































































 "At risk for psychiatric disorder" families
y” and “at risk for psychiatric disorder” families.
Table 3 Symptom dimension scores in relatives by family type
Total sample (N = 1392) “Healthy” (N = 637) “At risk” (N = 755) Test statistic (df) P
All relatives
CASH symptom dimensions Disorganization -.21 (.32) -.35 (.19) -.09 (.35) Wald (1) = 331 <.001
Negative -.21 (.29) -.36 (.18) -.08 (.29) Wald (1) = 500 <.001
Mania -.26 (.44) -.49 (.31) -.07 (.45) Wald (1) = 471 <.001
Depression -.31 (.58) -.65 (.44) -.03 (.53) Wald (1) = 631 <.001
Positive -.46 (.35) -.68 (.19) -.28 (.34) Wald (1) = 776 <.001
Parents N = 647 N= 289 N= 358
CASH symptom dimensions Disorganization -.19 (.34) -.32 (.25) -.09 (.37 Wald (1) = 84 <.001
Negative -.18 (.30) -.33 (.25) -.07 (.30) Wald (1) = 139 <.001
Mania -.27 (.39) -.45 (.35) -.13 (.37) Wald (1) = 125 <.001
Depression -.26 (.59) -.56 (.53) -.02 (.53) Wald (1) = 169 <.001
Positive -.46 (.31) -.64 (.22) -.31 (.30) Wald (1) = 258 <.001
Siblings N= 745 N= 348 N= 397
CASH symptom dimensions Disorganization -.23 (.29) -.38 (.10) -.09 (.33) Wald (1) = 272 <.001
Negative -.23 (.27) -.40 (.12) -.08 (.28) Wald (1) = 420 <.001
Mania -.25 (.48) -.52 (.27) -.01 (.49) Wald (1) = 316 <.001
Depression -.35 (.57) -.72 (.34) -.03 (.53) Wald (1) = 442 <.001
Positive -.46 (.37) -.71 (.15) -.24 (.37) Wald (1) = 539 <.001
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in the “at risk for psychiatric disorder” relatives are rela-
tively unaffected may suggest that these relatives do share
the risk for developing psychotic features with their affectedTable 4 A comparison of family and patient characteristics by
H
Patient characteristics (demographic)
Mean age (SD) 2
N male (%) 2
Patient characteristics (clinical)





Mean WAIS-IQ (SD) 9
CAN Met needs 3
Unmet needs 4
Patient characteristics (etiological)
Number of cannabis users (%) No abuse/dependence 1
dependence 7
abuse 2
dependence and abuse 1
Age of onset first psychosis 2family member while they do not share the risk for cogni-
tive deterioration. This would imply that negative symp-
toms, disorganization and cognitive decline are etiologically
distinct from the other symptom clusters.family type
ealthy (N= 272) At risk (N= 344) Test statistic (df) P
7.8 (7.7) 27.0 (7.5) Wald (1) = 1.43 .23
17 (79.8) 255 (74.1) Wald (1) = 2.69 .10
6 (.48) .57 (.46) Wald (1) = .15 .70
8 (.50) .59 (.47) Wald (1) = .03 .87
8 (.57) .60 (.55) Wald (1) = .20 .66
9 (.44) .43 (.41) Wald (1) = 1.09 .30
4 (.46) .84 (.45) Wald (1) = 6.63 .01
4.8 (15.24) 94.8 (15.66) Wald (1) = .00 .97
.26 (2.95) 3.21 (3.89) Wald (1) = .02 .89
.05 (2.92) 4.08 (3.07) Wald (1) = .04 .85
59 (58.5) 198 (57.6) Wald (3) = 7.94 .05
7 (28.3) 75 (21.8)
5 (9.2) 43 (12.5)
1 (4.0) 28 (8.1)
3.0 (7.2) 22.1 (6.7) Wald (1) = 2.72) .10
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the relatively high level of positive symptoms in patients
with schizophrenia in “at risk” families may not result
from the increased familial loading for psychosis but
may instead be related to the increased psychosis dimen-
sion scores in their relatives via a causal pathway
whereby higher positive scores in siblings or offspring
result in increased distress and lead to higher scores as a
reflection of familial distress due to a more severe pres-
entation of the illness. Such distress is more likely to be
reflected in mania, positive, and depression scores than
in disorganization and negative symptoms.
Cannabis abuse and/or dependence was not present at
significantly different rates in patients from “at risk for
psychiatric disorder” and “healthy” families. In addition,
age of onset of psychosis was not significantly different
between groups. Does this imply that our novel classifi-
cation for family types does not have an etiological basis?
Not necessarily, since the most important etiological risk
factor: genetic variation, was not yet taken into account.
Future studies should reveal whether genetic risk for
schizophrenia, for example such as calculated in the
study by Purcell and colleagues [27], may be significantly
different between subjects from “at risk for psychiatric
disorder” and “healthy” families. We hypothesize that
relatives from “at risk” families have a higher mean gen-
etic risk score compared to relatives from “healthy” fam-
ilies, even though the relatives in both family types do
not cross the threshold of “being affected”. If our symp-
tom based differentiation between “at risk” and “healthy”
families will be confirmed by genetic studies, this will
have important implications for future gene finding
studies. The statistical power to detect genetic risk fac-
tors involved in schizophrenia could be increased by
selecting those families with a high genetic loading.
The results of this study should be interpreted in view
of the following limitations. First, the design of this
study does not allow conclusions on the direction of
causality. It remains to be investigated whether the
higher positive scores in patients from “at risk for psy-
chiatric disorder” families are indicative of an increased
familial loading for psychosis or whether these higher
scores lead to higher psychosis dimension scores in the
relatives. Second, only a limited number of etiological
variables were assessed. So far, genetic variation appears
the most important risk factor for schizophrenia, but we
do not have the data needed to compare genetic risk be-
tween subtypes. Finally, while the advantage of our new
approach is the use of more refined measures to define
family subtypes, these refined measures are only avail-
able in the relatives who participated in the study. Not
all relatives were willing to participate and we can not
rule out the possibility that willingness to participate is
associated with the level of symptomatology.Conclusion
We have used a new approach to identify different fam-
ily subtypes based on the level of subclinical symptoms
in the relatives of schizophrenia patients. Our findings
confirm the existence of high-risk families and suggest
that future studies on the etiological factors of schizo-
phrenia should differentiate between individuals from
“at risk” and “healthy families”.
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